drugset / Trial / NCT01962753

Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)

NCT01962753

Completed 92 enrolled University Hospital, Tours
NaSingle-groupOpen-labelDiagnostic

Summary

The primary objective of the study is to compare the brain amyloid load in fully, partially and non remitting depressed elderly patients at 8 weeks of antidepressant therapy, by using PET with \[F18\]AV45.

Timeline

Start
2012-05-10
Primary completion
2020-01-22
Completion
2020-01-22

Drugs

EvaluationDrugModalityDoseRoute
Background Escitalopram Small molecule
Background Mirtazapine Other / unclassified
Background Moclamine Unknown
Background Paroxetine Small molecule
Background Sertraline Small molecule
Background Venlafaxine Small molecule